Abstract
ObjectivesTo report our experience in percutaneous radiofrequency ablation of renal tumors, emphasizing technical aspects and indications and analyzing our results. Material and methodsWe retrospectively analyzed 20 tumors in 13 patients (10 with a single kidney, 2 who had refused surgical treatment, and 1 with severe comorbidities). All procedures were performed using the radiofrequency interstitial tumor ablation (RITA) technique under general anesthesia and CT guidance. All patients underwent follow-up CT examination with and without intravenous contrast administration; the absence of enhancement was considered complete necrosis. ResultsThe mean size of the tumors was 2.8cm. Complete necrosis was achieved in 17 tumors (85%); complete necrosis was achieved in 100% of the exophytic tumors and in 50% of the tumors with mixed location after 14 months’ follow-up. Complete ablation was achieved in 15 of the 16 tumors measuring ≤ 3.5cm. In 9 of the 10 patients with a single kidney (four of whom had more than one tumor), renal function remained normal after the procedure; the other patient developed hydronephrosis after a urinary tract lesion and died. The patient who died also developed a subcapsular liver hematoma that did not require transfusion when another tumor was treated transhepatically. ConclusionIn experienced hands and with careful selection of patients (exophytic tumors ≤ 3.5cm), radiofrequency ablation of renal tumors can achieve excellent oncologic results with minimal morbidity and mortality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.